Irving, TX -- (SBWIRE) -- 07/26/2017 -- According to a new market report published by Lucintel, the future of the global cardiovascular device market looks good with opportunities in public and private hospitals. The global cardiovascular device market is expected to reach an estimated $69.3 billion by 2022, and it is forecast to grow at a CAGR of 4.3% from 2017 to 2022. The major drivers for market growth are growing demand for minimally invasive surgery, increasing healthcare expenditure, and growing geriatric population.
This report has 112 figures/charts and 84 tables spread through 197 pages. For more detail on this report please click link http://www.lucintel.com/cardiovascular-device-market-2017-2022.aspx
The cardiac rhythm management (CRM), interventional cardiac devices, peripheral vascular devices, cardiac assist devices, structural heart devices, cardiovascular surgery, electrophysiology, and diagnostic & monitoring devices are the main branches of global cardiovascular device market. On the basis of comprehensive research, Lucintel forecasts that the structural heart device, electrophysiology, cardiac assist device, and diagnostic & monitoring device segments are expected to show above average growth during the forecast period.
Download Free PDF Report Brochure here http://www.lucintel.com/rb/cardiovascular-device-market-2017-2022.aspx
Within the global cardiovascular device market, the CRM segment is expected to remain the largest segment. Increasing use of defibrillators mainly due to its cost effectiveness and safety is expected to result in significant growth of the CRM market.
Early buyers will receive 10% free customization on this report.
By device type, the global cardiovascular device market is segmented into pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, ECG, event monitor, and others. The defibrillator is the largest market mainly due to the development of technologically advanced defibrillators and rapid growth in the aging population with high risk of cardiovascular diseases.
North America is expected to remain the largest market during the forecast period mainly due to presence of a large size target patient pool coupled with high adoption rate for advanced treatments in this region.
APAC is expected to witness the highest growth over the forecast period due to growing health awareness, improved healthcare infrastructure along with an increasing spending capacity of the population in this region.
Emerging trends which have a direct impact on the dynamics of the industry include increasing demand of portable heart monitoring devices, rising adoption of transcatheter aortic valve replacement (TAVR) procedure, and increasing use of bioresorbable stents. Medtronic Public Limited Company, Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences Corporation, and Johnson & Johnson are among the major suppliers of cardiovascular devices.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global cardiovascular device market by type, device, and region, and has compiled a comprehensive research report entitled "Growth Opportunities in the Global Cardiovascular Device Market 2017-2022: Trends, Forecast, and Opportunity Analysis." The Lucintel report serves as a catalyst for growth strategy by providing comprehensive data and analysis on trends, key drivers, and directions.
Download free sample here http://www.lucintel.com/ds/cardiovascular-device-market-2017-2022.aspx
The study includes a forecast for the global cardiovascular device market by type, device, and region, as follows:
By Type [Value ($ Million) from 2011 to 2022]:
-Cardiac Rhythm Management
-Interventional Cardiac Devices
-Peripheral Vascular Devices
-Cardiac Assist Devices
-Structural Heart Devices
-Diagnostic & Monitoring Devices
By Device [Value ($ Million) from 2011 to 2022]:
By Region [Value ($ Million) from 2011 to 2022]:
For current press releases of Lucintel http://www.lucintel.com/press-release.aspx
This 197-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link http://www.lucintel.com/toc/cardiovascular-device-market-2017-2022.aspx or email@example.com.
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit http://www.lucintel.com.
Connect with us on LinkedIn here https://www.linkedin.com/company/lucintel?trk=top_nav_home
This report addresses the following key questions:
Q. 1. What are some of the most promising, high-growth opportunities for global cardiovascular device market by type, which includes cardiac rhythm management, interventional cardiac devices, peripheral vascular devices, cardiac assist devices, structural heart devices, cardiovascular surgery, electrophysiology, and diagnostic & monitoring devices, by device (pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve, ECG, event monitor, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q. 2. Which products segments will grow at a faster pace and why?
Q. 3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market and which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are being taken by key companies for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by product substitution?
Q. 11. What M&A activity has occurred in the last 5 years?